Editorial: Volume II: Tumor microenvironment in cancer hallmarks and therapeutics

Front Mol Biosci. 2023 Mar 28:10:1182083. doi: 10.3389/fmolb.2023.1182083. eCollection 2023.

Rongchen Shi^{1

2}, Yuan Gao², José Alexandre Ferreira³, Na Luo⁴, Hongming Miao²

¹ Frontier Medical Training Brigade, Third Military Medical University (Army Medical University), Xinjiang, China.
² Department of Pathophysiology, College of High Altitude Military Medicine, Third Military Medical University (Army Medical University), Chongqing, China.
³ Experimental Pathology and Therapeutics Group, Research Center of IPO Porto (CI-IPOP)/RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto)/Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC), Porto, Portugal.
⁴ Department of Anatomy and Histology, School of Medicine, Nankai University, Tianjin, China.

No abstract available

Keywords: cancer biomarkers; cancer immunotherapy; diagnosis; prognosis; tumor microenvironment.

Publication types